BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totaling 126,688 shares, a decline of 57.3% from the August 31st total of 296,445 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average trading volume of 188,153 shares, the short-interest ratio is presently 0.7 days.
BetterLife Pharma Stock Down 9.1%
Shares of BetterLife Pharma stock traded down $0.02 during midday trading on Monday, reaching $0.22. 49,216 shares of the company’s stock traded hands, compared to its average volume of 90,539. The company’s 50 day simple moving average is $0.22 and its 200 day simple moving average is $0.12. BetterLife Pharma has a 52 week low of $0.03 and a 52 week high of $0.33.
BetterLife Pharma Company Profile
BetterLife Pharma Inc is a Canadian biotechnology company focused on developing novel treatments for mental health and neurological conditions. Its research programs are centered on pharmaceutical compounds derived from or inspired by psychedelic substances, with the goal of creating therapies that may offer therapeutic benefits without the hallucinogenic effects associated with some traditional psychedelics.
The company’s development programs have included BETR-001, a synthetic derivative of lysergic acid diethylamide (LSD) being studied for potential applications in depression and other neuropsychiatric disorders, and BETR-002, an ibogaine-derived compound being investigated for substance-use disorders and related conditions.
See Also
- Five stocks we like better than BetterLife Pharma
- 2 China-Focused ETFs For After the Trump-Xi Summit
- 3 Dividend Stocks Investors May Be Missing in 2026
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
